Once Doubted, WHO Congrats Russia on the Sputnik V Vaccine

Russia has helped provide assistance to Central Asian countries during the pandemic.

World Health Organization (WHO) appreciates the efforts of scientists in Russia in developing a safe and effective Sputnik V vaccine. Sputnik V is the first officially registered Covid-19 vaccine made in Russia, developed by the Gamaleya Research Institute for Epidemiology and Microbiology, which has now entered phase three clinical trials involving 2,000 volunteers.

“WHO really appreciates the efforts that Russia has made in developing a vaccine against Covid-19, namely the Sputnik V Vaccine, I would like to once again thank Russia for its excellent efforts to create a safe and effective vaccine,” explained WHO’s European Regional Director, Hans Kluge, after meeting with Russian Health Minister Mikhail Murashko, quoted from merdeka.com, Tuesday 22 September 2020.

Hans also said that Russia had helped him provide assistance to Central Asian countries in times of the pandemic, and had generally shown its commitment to global solidarity.

1 of 3 pages

Safe and Effective Vaccine, Available January 2021

The Russian Ministry of Health has confirmed that the vaccine underwent all the necessary tests and proved capable of building immunity against the virus for at least two years. The Russian government also announced that the discovered vaccine will start production in early September 2020. Meanwhile, its worldwide availability is expected to be distributed starting in January 2021.

Once Doubted
Once Doubted, WHO Congrats Russia on the Sputnik V Vaccine

Moscow itself is said to have received requests for one billion doses of vaccine from at least 20 countries, but authorities say they will serve its people first.

2 of 3 pages

Brazil Becomes Test Country for Covid-19 Vaccine from Russia

Now, the Covid-19 vaccine is being tested in several countries in order to find one that really works to overcome the pandemic. One of the countries that is currently producing a candidate for the Covid-19 vaccine in Russia. However, they are conducting trials in other countries, namely Brazil.

The Brazilian state of Bahia has recently become the site of Phase 3 clinical trial for the Sputnik-V vaccine. The plan is that 50 million doses of the vaccine will be marketed. This was agreed on September 8 with the signing of an agreement between Russia and the Governor of the State of Bahia, Rui Costa.

Currently, Costa also continues to strengthen international relations to help develop the Covid-19 vaccine. In fact, it is planned that Bahia will receive 500 doses after being approved by the Brazilian health regulator, Anvisa.

3 of 3 pages

Will be marketed in Bahiafarma

If Sputnik-V is proven successful in overcoming Covid-19 in October, Bahia will start marketing it through the Bahiafarma pharmaceutical research center. The good news is that Russia is starting to call Sputnik-V a Covid-19 vaccine even though trials are not yet complete. Apparently, this belief is shared by the authorities in the state who will buy 50 million doses of Sputnik-V.

This was acknowledged by the Chief Executive of the Russian Direct Investment Fund (RDIF), Kiril Dmitriev on September 10. “Another major Brazilian state has agreed to get 50 million doses of vaccine,” said Dmitriev. However, he did not clearly state the state in question.

Leave a Reply

Your email address will not be published. Required fields are marked *